Use of dufastone in therapy of pregnancy loss

Cover Page


Cite item

Full Text

Abstract

The study purpose is realizing efficiency of synthetic analog of progesterone-dufastone (didrogesterone) for threatening abort therapy and dynamics evaluation of blood progesterone contents during treatment with dufastone. Dufastone use is pathogenetically proved, its high efficiency for treatment of pregnancy loss at early terms is affirmed. Dufastone application helps to protect pregnancy and has not negative influences on pregnant woman and fetus state. 93,5% of pregnancies in women with fetus loss in anamnesis were completed with deliveries.

About the authors

O. A. Arjanova

Research Institute of Obstetrics, Gynecology and Reproductology named after D.O. Ott

Author for correspondence.
Email: info@eco-vector.com
Russian Federation, Saint Petersburg

I. V. Kovaliova

Research Institute of Obstetrics, Gynecology and Reproductology named after D.O. Ott

Email: info@eco-vector.com
Russian Federation, Saint Petersburg

References

Supplementary files

Supplementary Files
Action
1. JATS XML
2. Figure. The content of progesterone in the blood plasma of pregnant women with the threat of interruption after treatment with duphaston

Download (21KB)

Copyright (c) 2003 Eсо-Vector



Согласие на обработку персональных данных

 

Используя сайт https://journals.rcsi.science, я (далее – «Пользователь» или «Субъект персональных данных») даю согласие на обработку персональных данных на этом сайте (текст Согласия) и на обработку персональных данных с помощью сервиса «Яндекс.Метрика» (текст Согласия).